Research Studies
Back to Results
An open-label, single arm, roll-over study to provide continued treatment with darolutamide in participants who were enrolled in previous Bayer-sponsored studies
Details
Age
Adult
Phase
III - Research Studies that gather more information about a drug's safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. These studies typically involve more participants.
Type of Study
Treatment
Location
Rocky Mountain Regional VA Medical Center
Principal Investigator
Daniel Bowles
Study ID
Protocol Number: 20-1948
More information available at ClinicalTrials.gov: NCT04464226
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers